NM_002846.4:c.2716A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002846.4(PTPRN):​c.2716A>G​(p.Ile906Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

PTPRN
NM_002846.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.18

Publications

1 publications found
Variant links:
Genes affected
PTPRN (HGNC:9676): (protein tyrosine phosphatase receptor type N) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single catalytic domain, and thus represents a receptor-type PTP. This PTP was found to be an autoantigen that is reactive with insulin-dependent diabetes mellitus (IDDM) patient sera, and thus may be a potential target of autoimmunity in diabetes mellitus. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19760865).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTPRNNM_002846.4 linkc.2716A>G p.Ile906Val missense_variant Exon 20 of 23 ENST00000295718.7 NP_002837.1 Q16849-1Q96IA0
PTPRNNM_001199763.2 linkc.2629A>G p.Ile877Val missense_variant Exon 19 of 22 NP_001186692.1 Q16849-2
PTPRNNM_001199764.2 linkc.2446A>G p.Ile816Val missense_variant Exon 20 of 23 NP_001186693.1 Q16849-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTPRNENST00000295718.7 linkc.2716A>G p.Ile906Val missense_variant Exon 20 of 23 1 NM_002846.4 ENSP00000295718.2 Q16849-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000796
AC:
2
AN:
251394
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461774
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111962
Other (OTH)
AF:
0.00
AC:
0
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 14, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2716A>G (p.I906V) alteration is located in exon 20 (coding exon 20) of the PTPRN gene. This alteration results from a A to G substitution at nucleotide position 2716, causing the isoleucine (I) at amino acid position 906 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;T;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
-1.1
.;N;.
PhyloP100
3.2
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-0.74
N;N;.
REVEL
Benign
0.29
Sift
Benign
0.38
T;T;.
Sift4G
Benign
0.24
T;T;T
Polyphen
0.0010
.;B;.
Vest4
0.40
MutPred
0.49
.;Loss of catalytic residue at V907 (P = 0.101);.;
MVP
0.61
MPC
0.37
ClinPred
0.34
T
GERP RS
4.9
Varity_R
0.11
gMVP
0.29
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746870525; hg19: chr2-220156205; API